April 2016 ARTICLE LIST >>
PharmaTutor (April- 2016)
Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 4, Issue 4)
Received On: 11/10/2015; Accepted On: 21/10/2015; Published On: 01/04/2016
AUTHORS:
Patel Vishakha. D.*, Raj Hasumati, Gheewala Nirav
Department of Quality Assurance, Shree Dhanvantary Pharmacy College, Kim, Dist: Surat
*vishuk7293@gmail.com
ABSTRACT: Ranolazine is a piperazine derivative is a new anti-ischemic drug for the treatment of angina.
Ranolazine is to inhibit late INa thus preventing sodium overload of the cell. As a consequence, ranolazine prevents reverse mode sodium-calcium exchange and thus diastolic accumulation of calcium possibly resulting in improved diastolic tone and improved coronary blood flow.
This review article represent the various analytical methods which has been reported for estimation of Ranolazine in synthetic mixture. The spectrophotometric techniques like fluorescent assay and area under curve spectroscopy; Chromatogrraphic methods like HPLC, HPTLC and RP HPLC, GC, LC-MS, LC-MS/MS were reported.
How to cite this article: Patel VD, Raj H, Gheewala N; A Review on Analytical Methods for Ranolazine determination in synthetic mixture; PharmaTutor; 2016; 4(4); 28-31
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Ranolazine Drug Info.(database available on internet):Drug Bank. Available from: drugbank.ca/drugs/DB00243 ran Ranolazine Drug Info.(database available on internet):Chemical Book. Available from: pubchem.ncbi.nlm.nih.gov/compound/ranolazine
Ranolazine Drug Info.(database available on internet):Chemical Book. Available from: scbt.com/datasheet-212769-ranolazine.html
2. Hasenfuss G, Maier L.S, “Mechanism of action of the new anti-ischemia drug ranolazine.” Clinical Research Cardiology, 2008, 97(4), 222-226
3. Parvathareddy S, Desam N, Nuthalapati M, B.T, “Development and Validation of Hplc and UV methods for estimation of Ranolazine in Bulk and Marketed formulation.” International journal of Innovative Pharmaceutical Sciences and Research, 2014, 2(5), 1042-1058
4. Patel R.C, Rathod D.K, Patel P.R, Patel V.S, “Estimation of Ranolazine Hydrochloride by Spectrophotometric and RP-HPLC in tablet dosage forms.” International Journal of Pharmaceutical and Appiled Sciences, 2010, 1(2), 79-83
5. Sharma T, Moitra S.K, Si.S.C, Sankar D.G, “Stability indicating LC method for the determination of Ranolazine Hydrochloride in the bulk drug and in pharmaceutical dosage form.” International Journal of Pharmacy and Pharmaceutical Sciences, 2011, 3(4), 327-332
6. Lei T, Juanjuan J, Yiling H, Lu H, Hong L, Yishi L, “Sensitive quantification of Ranolazine in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionization.” Journal of Chromatography B, 2007, 846(1-2), 346-350
7. Bai S, Gao H, Qu H, Liang Y, Li Y, Zheng Z, Wang X, Hao G, “Quantitative determination of Ranolazine in human plasma by high performance liquid chromatography-tandem mass spectrometry.” Northwest Pharmaceutical Journal, 2011
8. Zhao L, Li H, Jiang Y, Piao R, Li P, Gu J , “Determination of Ranolazine in human plasma by liquid chromatographic-tandem Mass Spectrometric assay.”Journal of Chromatographic Science, 2008, 46(8), 697-700
9. Khedkar A.N, Veer S.U, Rakh M.S, Rao J.R, “Stability indicating method development and validationof Ranolazine Hydrochloride in bulk and tablet dosage form by HPTLC.” International Journal of Pharmaceutical and Clinical Research, 2015, 7(1), 77-83
10. Ye YL, Yang XM, “Determination of residual solvent in Ranolazine by headspace gas chromatography.” Nan Fang Yi Ke Da Xue Bao, 2008, 28(1), 134-135
11. J.K, K.R, R.K, N.S, “Method development and Validation for the Estimation of Ranolazine in Bulk and in Pharmaceutical Dosage Form by UV-Spectrophotometry.”Annals of Pharma Research , 2013, 1(1), 4-7
12. Ugale J. B, Mulgund S. V, “Development and Validation of UV Spectrophotometric Area under cure method for Quantitative Estimation of Ranolazine in API and Tablet Formulation.”World journal of Pharmaceutical Research, 2015,4(5), 2665-2672
13. Guada M, Imbuluzqueta E, Estella-Hermoso de Mendoza A, Lana H, Dios-vieitez M.C, Blanco-Prieto M.J, “Ultra high performance liquid chromatography-tandem mass spectrometry method for cyclosporine a quantification in biological samples and lipid nanosystems.”J Chromatogr B Analyt Technol Biome Life Sci., 2013, 927, 164-172
14. Nahid A, Pavani H, “Development and Validation of HPLC method for simultaneous dtermination of Ranolazine and Dronederone in bulk and pharmaceutical dosage forms.” Indian Journal of research in Pharmacy and Biotechnology, 2015, 2(6), 1524-1528
.png)
